AbbVie Proves Masterful at Playing Drug Patent Game
AbbVie uses dozens of patents to ward off competition for a pricey cancer medicine
AbbVie, already famous for its Humira strategy, forms another ‘patent wall’ around Imbruvica: report
Why are Drug Prices So High? Investigating the outdated US patent system
How Big Pharma secures drug monopolies
Report Finds 89% of Total U.S. Patent Applications on Humira Were Filed After FDA Approval – Pointing to a Deliberate Strategy to Delay Competition
Femtastic Podcast: How Patent Law Affects Your Health
Patent abuse is driving up drug prices. Just look at Lantus
Wall Street Wants the Best Patents, Not the Best Drugs
Pharma patent owners in the US are under pressure like they have never been before